Epigenetic modification in 4T1 mouse breast cancer model by artificial light at night and melatonin – the role of DNA-methyltransferase

References

• Al-Naggar RA, Anil SH. 2016. Artificial light at night and cancer: global study. Asian Pac J Cancer Prev. 17:4661–4664.
   PubMedGoogle Scholar
• Arendt J. 1998. Melatonin and the pineal gland: influence on mammalian seasonal and circadian physiology. Rev Reprod. 3:13–22.
   PubMedGoogle Scholar
• Ballestar E, Esteller M. 2008. Epigenetic gene regulation in cancer. Adv Genet. 61:247–267.
   PubMed Web of Science ®Google Scholar
• Bartsch C, Bartsch H. 2006. The anti-tumor activity of pineal melatonin and cancer enhancing life styles in industrialized societies. Cancer Causes Control. 17:559–571.
   PubMed Web of Science ®Google Scholar
• Beheshti A, Wage J, McDonald JT, Lamont C, Peluso M, Hahnfeldt P, Hlatky L. 2015. Tumor-host signaling interaction reveals a systemic, age-dependent splenic immune influence on tumor development. Oncotarget. 6:35419.
   PubMedGoogle Scholar
• Bestor T, Laudano A, Mattaliano R, Ingram V. 1988. Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. The carboxyl-terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases. J Mol Biol. 203:971–983.
   PubMed Web of Science ®Google Scholar
• Blamey RW, Evans DM. 1971. Spleen weight in rats during tumour growth and in homograft rejection. Br J Cancer. 25:527–532.
   PubMed Web of Science ®Google Scholar
• Blask DE, Brainard GC, Dauchy RT, Hanifin JP, Davidson LK, Krause JA, Sauer LA, Rivera-Bermudez MA, Dubocovich ML, Jasser SA, et al. 2005. Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Cancer Res. 65:11174–11184.
   PubMed Web of Science ®Google Scholar
• Blask DE, Hill SM, Dauchy RT, Xiang S, Yuan L, Duplessis T, Mao L, Dauchy E, Sauer LA. 2011. Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night. J Pineal Res. 51:259–269.
   PubMed Web of Science ®Google Scholar
• Boyle P, Levin B. 2008. World cancer report. IARC Press. http://publications.iarc.fr/Non-Series-Publications/World-Cancer-Reports/World-Cancer-Report-2008
   Google Scholar
• Bronte V, Pittet MJ. 2013. The spleen in local and systemic regulation of immunity. Immunity. 39:806–818.
   PubMed Web of Science ®Google Scholar
• Brueckner B, Lyko F. 2005. DNA methyltransferases inhibitors: old and new drugs for an epigenetic cancer therapy. Trends Pharmacol Sci. 25:551–554.
   Web of Science ®Google Scholar
• Bullough JD, Rea MS, Figueiro MG. 2006. Of mice and women: light as a circadian stimulus in breast cancer research. Cancer Causes Control. 17:375–383.
   PubMed Web of Science ®Google Scholar
• Connolly R, Stearns V. 2012. Epigenetics as a therapeutic target in breast cancer. J Mammary Gland Bio Neoplasia. 17:191–204.
   PubMed Web of Science ®Google Scholar
• Cos S, Sánchez-Barceló EJ. 2000. Melatonin and mammary pathological growth. Front Neuroendocrinol. 21:133–170.
   PubMed Web of Science ®Google Scholar
• de Almeida EA, Di Mascio P, Harumi T, Spence DW, Moscovitch A, Hardeland R, Cardinali DP, Brown GM, Pandi-Perumal SR. 2011. Measurement of melatonin in body fluids: standards, protocols and procedures. Childs Nerv Syst. 27:879–891.
   PubMed Web of Science ®Google Scholar
• Egger G, Liang G, Aparicio A, Jones PA. 2004. Epigenetics in human disease and prospects for epigenetic therapy. Nature. 429:457–463.
   PubMed Web of Science ®Google Scholar
• Esteller M. 2005. Aberrant DNA methylation as a cancer-inducing mechanism. Annu rev Pharmacol toxicol. 45:629–656.
   PubMed Web of Science ®Google Scholar
• Esteller M. 2008. Epigenetics in cancer. N Engl J Med. 358:1148–1159.
   PubMed Web of Science ®Google Scholar
• Esteller M, Fraga MF, Guo M, Garcia-Foncillas J, Hedelfank I, Godwin AK, Trojan J, Vaurs-Barriere C, Bignon J, Ramus S, et al. 2001. DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Human Mol Gen. 10:3001–3007.
   PubMed Web of Science ®Google Scholar
• Falchi F, Cinzano P, Elvidge D, Keith M, Haim A. 2011. Limiting the impact of light pollution on human health, environment and stellar visibility. J Environ Manage. 92:2714–2722.
   PubMed Web of Science ®Google Scholar
• Feinberg AP, Vogelstein B. 1983. Melatonin function: hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature. 301:89–92.
   PubMed Web of Science ®Google Scholar
• Fonken K, Aubrecht G, Meléndez-Fernández H, Weil M, Nelson J. 2013. Dim light at night disrupts molecular circadian rhythms and affects metabolism. J Bio Rhythms. 28:262–271.
   PubMed Web of Science ®Google Scholar
• Fonken K, Workman L, Walton C, Weil M, Morris S, Haim A, Nelson J. 2010. Light at night increases body mass by shifting the time of food intake. Proc Natl Acad Sci USA. 107:18664–18669.
   PubMed Web of Science ®Google Scholar
• Foster BA, Gingrich JR, Kwon ED, Madias C, Greenberg NM. 1997. Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model. Cancer Res. 57:3325–3330.
   PubMed Web of Science ®Google Scholar
• Gaston KJ, Duffy JP, Gaston S, Bennie J, Davies TW. 2014. Human alteration of natural light cycles: causes and ecological consequences. Oecol. 176:917–931.
   PubMed Web of Science ®Google Scholar
• Gerds A, Su D, Martynova A, Pannell B, Mukherjee S, O’Neill C, Sekeres M, O’Connell C. 2018. Ruxolitinib rechallenge can improve constitutional symptoms and splenomegaly in patients with myelofibrosis: a Case Series. Clin Lymphoma Myeloma Leuk. 18:e463–e468.
   PubMed Web of Science ®Google Scholar
• Gouthiere L, Mauvieux B, Davenne D, Waterhouse J. 2005. Complementary methodology in the analysis of rhythmic data, using examples from a complex situation, the rhythmicity of temperature in night shift workers. Biol Rhythm Res. 36:177–193.
   Web of Science ®Google Scholar
• Haim A, Portnov BA. 2013. Light pollution as a new risk factor for human breast and prostate cancers. Dordrecht, The Netherlands: Springer science+Business Media.
   Google Scholar
• Haim A, Zubidat AE. 2015. Artificial light at night – melatonin as a mediator between the environment and epigenome. Philos Trans R Soc B Biol Sci. 370:20140121.
   PubMed Web of Science ®Google Scholar
• He C, Anand ST, Ebell MH, Vena JE, Robb SW. 2014. Circadian disrupting exposures and breast cancer risk: a meta-analysis. Int Arch Occup Environ Health. 88:533–547.
   PubMed Web of Science ®Google Scholar
• Higashijima J, Shimada M, Chikakiyo M, Miyatani T, Yoshikawa K, Nishioka M, Iwata T, Kurita N. 2009. Effect of splenectomy on antitumor immune system in mice. Anticancer Res. 29:385–393.
   PubMed Web of Science ®Google Scholar
• Hill SM, Belancio VP, Dauchy RT, Xiang S, Brimer S, Mao L, Hauch A, Lundberg PW, Summers W, Yuan L, et al. 2015. Melatonin: an inhibitor of breast cancer. Endocr Relat Cancer. 2:R183–R204.
   Web of Science ®Google Scholar
• Hill SM, Blask DE, Xiang S, Yuan L, Mao L, Dauchy RT, Dauchy EM, Frasch T, Duplesis T. 2011. Melatonin and associated signaling pathways that control normal breast epithelium and breast cancer. J Mammary Gland Biol Neoplasia. 16:235–245.
   PubMed Web of Science ®Google Scholar
• Holliday R. 2006. Epigenetics: a historical overview. Epigenetics. 1:76–80.
   PubMed Web of Science ®Google Scholar
• Imai S, Nio Y, Shiraishi T, Tsubono M, Morimoto H, Tseng CC, Kawabata K, Masai Y, Tobe T. 1991. Effects of splenectomy on pulmonary metastasis and growth of SC42 carcinoma transplanted into mouse liver. J Surg Oncol. 47:178–187.
   PubMed Web of Science ®Google Scholar
• James P, Bertrand KA, Hart JE, Schernhammer ES, Tamimi RM, Laden F. 2017. Outdoor light at night and breast cancer incidence in the nurses’ health study II. Environ Health Perspect. 25:087010.
   Web of Science ®Google Scholar
• Jardim-Perassi BV, Arbab AS, Ferreira LC, Borin TF, Varma NRS, Iskander ASM, Shankar A, Ali MM, de Campos Zuccari DA, Rocha S. 2014. Effect of melatonin on tumor growth and angiogenesis in xenograft model of breast cancer. PLoS One. 9:e85311.
   PubMed Web of Science ®Google Scholar
• Keshet-Sitton A, Or-Chen K, Yitzhak S, Tzabary I, Haim A. 2017. Light and the city: breast cancer risk factors differ between Urban and Rural women in Israel. Integr Cancer Ther. 16:176–187.
   PubMed Web of Science ®Google Scholar
• Kim YJ, Park MS, Lee E, Choi JW. 2016. High incidence of breast cancer in light-polluted areas with spatial effects in Korea. Asian Pac J Cancer Prev. 17:361–367.
   PubMedGoogle Scholar
• Kloog I, Haim A, Stevens RG, Barchana M, Portnov BA. 2008. Light at night co-distributes with incident breast but not lung cancer in the female population of Israel. Chronobiol Int. 25:65–81.
   PubMed Web of Science ®Google Scholar
• Kloog I, Stevens RG, Haim A, Portnov BA. 2010. Nighttime light level co-distributes with breast cancer incidence worldwide. Cancer Causes Control. 21:2059–2068.
   PubMed Web of Science ®Google Scholar
• Korkmaz A, Reiter RJ. 2008. Epigenetic regulation: a new research area for melatonin? J Pineal Res. 44:41–44.
   PubMed Web of Science ®Google Scholar
• Korkmaz A, Topal T, Tan X, Reiter J. 2009. Role of melatonin in metabolic regulation. Rev Endocr Metab Disord. 10:261–270.
   PubMed Web of Science ®Google Scholar
• Kurien BT, Everds NE, Scofield RH. 2004. Experimental animal urine collection: a review. Lab Anim. 38:333–3361.
   PubMed Web of Science ®Google Scholar
• Lee SE, Kim SJ, Yoon HJ, Yu SY, Yang H, Jeong SI, Hwang SY, Park CS, Park YS. 2013. Genome-wide profiling in melatonin-exposed human breast cancer cell lines identifies differentially methylated genes involved in the anticancer effect of melatonin. J Pineal Res. 54:80–88.
   PubMed Web of Science ®Google Scholar
• Leonardi GC, Rapisarda V, Marconi A, Scalisi A, Catalano F, Proietti L, Travali S, Libra M, Fenga C. 2012. Correlation of the risk of breast cancer and disruption of the circadian rhythm. Oncol Rep. 28:418–428.
   PubMed Web of Science ®Google Scholar
• Lockley SW, Brainard GC, Czeisler CA. 2003. High sensitivity of the human circadian melatonin rhythm to resetting by short wavelength light. J Clin Endocrinol Metab. 88:4502–4505.
   PubMed Web of Science ®Google Scholar
• Lyko F, Brown R. 2005. DNA methyltransferase inhibitors and the development of epigenetic cancer therapies. J Natl Cancer Inst. 97:1498–1506.
   PubMed Web of Science ®Google Scholar
• Mäntele S, Otway DT, Middleton B, Bretschneider S, Wright J, Robertson MD, Skene DJ, Johnston JD, Tosini G. 2012. Daily rhythms of plasma melatonin, but not plasma leptin or leptin mRNA, vary between lean, obese and type 2 diabetic men. PLoS One. 7:e37123.
   PubMed Web of Science ®Google Scholar
• Menaker M, Murphy C, Sellix T. 2013. Central control of peripheral circadian oscillators. Curr Opin Neurobiol. 23:741–746.
   PubMed Web of Science ®Google Scholar
• Mustonen M, Nieminen P, Hyvärinen H. 2001. Preliminary evidence that pharmacologic melatonin treatment decreases rat ghrelin levels. Endocrine. 16:43–46.
   PubMed Web of Science ®Google Scholar
• Nakaoka T, Saito Y, Saito H 2017. Aberrant DNA methylation as a biomarker and a therapeutic target of cholangiocarcinoma. Int J Mol Sci. 18(E1111). doi:10.3390/ijms18061111.
   PubMed Web of Science ®Google Scholar
• Nelson W, Tong Y, Lee J, Halberg F. 1979. Methods for cosinor-rhythmometry. Chronobiologia. 6:305–323.
   PubMedGoogle Scholar
• Pandi-Perumal SR, Srinivasan V, Maestroni GJ, Cardinali DP, Poeggeler B, Hardeland R. 2006. Melatonin: nature`s most versatile biological signal? The FEBS J. 273:813–2838.
   Web of Science ®Google Scholar
• Parkin DM, Bray F, Ferlay J, Pisani P. 2005. Global cancer statistics. 2002. CA Cancer J Clin. 55:74–108.
   PubMed Web of Science ®Google Scholar
• Partha MD, Singal R. 2004. DNA methylation and cancer. J Clinl Onco. 22:4632–4642.
   PubMed Web of Science ®Google Scholar
• Peng L, Yuan Z, Ling H, Fukasawa K, Robertson K, Olashaw N, Koomen J, Chen J, Lane WS, Seto E. 2011. SIRT1 deacetylates the DNA methyltransferase 1 (DNMT1) protein and alters its activities. Mol Cell Biol. 31:4720–4734.
   PubMed Web of Science ®Google Scholar
• Pulaski BA, Ostrand-Rosenberg S. 2001. Mouse 4T1 breast tumor model. Curr Protoc in Immunol. Chapter 20:Unit 20.2. doi:10.1002/0471142735.im2002s39.
   PubMedGoogle Scholar
• Reiter RJ, Fraschini F. 1969. Endocrine aspects of the mammalian pineal gland: a review. Neuroendocrinol. 5:219–255.
   PubMed Web of Science ®Google Scholar
• Revell VL, Skene DJ. 2007. Light-induced melatonin suppression in humans with polychromatic and monochromatic light. Chronobiol Int. 24:1125–1137.
   PubMed Web of Science ®Google Scholar
• Robert MF, Morin S, Beaulieu N, Gauthier F, Chute IC, Barsalou A, MacLeod AR. 2003. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat gene. 33:61–65.
   PubMed Web of Science ®Google Scholar
• Roberts JG, Wisbey M, Leach KG, Baum M. 1975. Proceedings: spleen size in patients with breast cancer. Br J Cancer. 31:262.
   PubMed Web of Science ®Google Scholar
• Schernhammer ES, Berrino F, Krogh V, Secreto G, Micheli A, Venturelli E, Sieri S, Sempos CT, Cavalleri A, Schünemann HJ, et al. 2008. Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 100:898–905.
   PubMed Web of Science ®Google Scholar
• Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, Colditz GA. 2001. Rotating night shifts and risk of breast cancer in women participating in the nurses health study. J Natl Cancer Inst. 93:1563–1568.
   PubMed Web of Science ®Google Scholar
• Schoorlemmer GH, Johnson AK, Thunhorst RL. 2001. Circulating angiotensin II mediates sodium appetite in adrenalectomized rats. Am J Physiol Regul Integr Comp Physiol. 281:R723–R729.
   PubMed Web of Science ®Google Scholar
• Schwimmer H, Metzer A, Pilosof Y, Szyf M, Machnes ZM, Fares F, Harel O, Haim A. 2014. Light at night and melatonin have opposite effects on breast cancer tumors in mice assessed by growth rates and global DNA methylation. Chronobiol Int. 31:44–150.
   Web of Science ®Google Scholar
• Shiratori Y, Kawase T, Nakata R, Tanaka M, Hikiba Y, Okano K, Matsumura M, Niwa Y, Komatsu Y, Shiina S. 1995. Effect of splenectomy on hepatic metastasis of colon carcinoma and natural killer activity in the liver. Dig Dis Sci. 40:2398–2406.
   PubMed Web of Science ®Google Scholar
• Sonoda K, Izumi K, Matsui Y, Inomata M, Shiraishi N, Kitano S. 2006. Decreased growth rate of lung metastatic lesions after splenectomy in mice. Eur Surg Res. 38:469–475.
   PubMed Web of Science ®Google Scholar
• Spoor MS, Radi ZA, Dunstan RW. 2008. Characterization of age- and gender-related changes in the spleen and thymus from control cynomolgus macaques used in toxicity studies. Toxicol Pathol. 36:695–704.
   PubMed Web of Science ®Google Scholar
• Srinivasan V, Spence DW, Pandi-Perumal SR, Trakht I, Esquifino AI, Cardinali DP, Maestroni GJ. 2008. Melatonin, environmental light, and breast cancer. Breast Cancer Res Treat. 108:339–350.
   PubMed Web of Science ®Google Scholar
• Stevens RG, Brainard GC, Blask DE, Lockley SW, Motta ME. 2014. Breast cancer and circadian disruption from electric lighting in the modern world. CA Cancer J Clin. 64:207–218.
   PubMed Web of Science ®Google Scholar
• Stevens RG, Davis S. 1996. The melatonin hypothesis: electric power and breast cancer. Environ Health Perspect. 1:135–140.
   Google Scholar
• Tamarkin L, Cohen M, Roselle D, Reichert C, Lippman M, Chabner B. 1981. Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat. Cancer Res. 41:4432–4436.
   PubMed Web of Science ®Google Scholar
• Tan X, Mancheste C, Fuentes-Broto L, Paredes D, Reiter J. 2011. Significance and application of melatonin in the regulation of brown adipose tissue metabolism: relation to human obesity. Obes Rev. 12:167–188.
   PubMed Web of Science ®Google Scholar
• Tendron-Franzin A, Gouyon JB, Guignard JP, Decramer S, Justrabo E, Gilbert T, Semama DS. 2004. Long-term effects of in utero exposure to cyclosporin A on renal function in the rabbit. J Am Soc Nephrol. 15:2687–2693.
   PubMed Web of Science ®Google Scholar
• Touitou Y, Reinberg A, Touitou D. 2017. Association between light at night, melatonin secretion, sleep deprivation, and the internal clock: health impacts and mechanisms of circadian disruption. Life Sci. 173:94–106.
   PubMed Web of Science ®Google Scholar
• Touitou Y, Smolensky MH, Portaluppi F. 2006. Ethics, standards and procedures in human and animal research in chronobiology. Chronobiol Int. 23:1083–1096.
   PubMed Web of Science ®Google Scholar
• Tschöp M, Smiley L, Heiman L. 2000. Ghrelin induces adiposity in rodents. Nature. 4:908–913.
   Web of Science ®Google Scholar
• Vriend J, Lauber JK. 1973. Letter: effects of light intensity, wavelength and quanta on gonads and spleen of the deer mouse. Nature. 244:37–38.
   PubMed Web of Science ®Google Scholar
• Wang J, Xiao X, Zhang Y, Shi D, Chen W, Fu L, Liu L, Xie F, Kang T, Huang W, et al. 2012. Simultaneous modulation of COX-2, p300, Akt, and Apaf-1 signaling by melatonin to inhibit proliferation and induce apoptosis in breast cancer cells. J Pineal Res. 53:77–90.
   PubMed Web of Science ®Google Scholar
• Wang ZY, Huang MT, Ho CT, Chang R, Ma W, Ferraro T, Reuhl KR, Yang CS, Conney AH. 1992. Inhibitory effect of green tea on the growth of established skin papillomas in mice. Cancer Res. 2:6657–6665.
   Google Scholar
• Wen S, W Everitt SJ, Bedő J, Chabrot M, Ball DL, Solomon B, MacManus M, Hicks RJ, Möller A, Leimgruber A, et al. 2015. Spleen volume variation in patients with locally advanced non-small cell lung cancer receiving platinum-based chemo- radiotherapy. PLoS One. 10:e0142608.
   PubMed Web of Science ®Google Scholar
• Yamagishi H, Pellis NR, Macek C, Kahan BD. 1980. Changes in spleen morphology and lymphoid cell activity during tumor progression. Eur J Cancer. 16:1417–1426.
   PubMed Web of Science ®Google Scholar
• Zeman M, Szántóová K, Stebelová K, Mravec B, Herichová I. 2009. Effect of rhythmic melatonin administration on clock gene expression in the suprachiasmatic nucleus and the heart of hypertensive TGR(mRen2)27 rats. J Hypertens. 27:S21–S26.
   Web of Science ®Google Scholar
• Zhang B, Zhou Y, Lin N, Lowdon RF, Hong C, Nagarajan RP, Cheng JB, Li D, Stevens M, Lee HJ, et al. 2013. Functional DNA methylation differences between tissues, cell types, and across individuals discovered using the M&M algorithm. Genome Res. 23:1522–1540.
   PubMed Web of Science ®Google Scholar
• Zhdanova IV, Friedman L. 2008. Therapeutic potential of melatonin in sleep and circadian disorders. In: Mischoulon D, Rosenbaum JF, editors. Psychiatry natural medications for psychiatric disorders: considering the alternatives. 2nd ed. Philadelphia, USA: Lippincott Williams &Wilkins; p. 140–163.
   Google Scholar
• Zhu Y, Stevens RG, Hoffman AE, Tjonneland A, Vogel UB, Zheng T, Hansen J. 2011. Epigenetic impact of long-term shiftwork: pilot evidence from circadian genes and whole-genome methylation analysis. Chronobiol Int. 28:852–861.
   PubMed Web of Science ®Google Scholar
• Zubidat AE, Fares B, Fares F, Haim A. 2015. Melatonin function through DNA methylation to constricts breast cancer growth accelerated by blue LED light-at-night in 4T1 tumor-bearing mice. J Cancer Biol Therap. 1:57–73.
   Google Scholar
• Zubidat AE, Fares B, Fares F, Haim A. 2018. Artificial light-at-night of different spectral compositions differentially affects tumor growth in mice: interaction with melatonin and epigenetic pathways. Cancer Control. 25:1073274818812908.
   Web of Science ®Google Scholar
• Zubidat AE, Nelson RJ, Haim A. 2009. Photosensitivity to different light intensities in blind and sighted rodents. J Exp Biol. 212:3857–3864.
   PubMed Web of Science ®Google Scholar